Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
05 07 2021
Historique:
received: 16 08 2020
accepted: 14 06 2021
entrez: 6 7 2021
pubmed: 7 7 2021
medline: 14 7 2021
Statut: epublish

Résumé

Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology underlying COVID-19 severity, we perform cytokine and multiplex immune profiling in COVID-19 patients. We show that hypercytokinemia in COVID-19 differs from the interferon-gamma-driven cytokine storm in macrophage activation syndrome, and is more pronounced in critical versus mild-moderate COVID-19. Systems modelling of cytokine levels paired with deep-immune profiling shows that classical monocytes drive this hyper-inflammatory phenotype and that a reduction in T-lymphocytes correlates with disease severity, with CD8+ cells being disproportionately affected. Antigen presenting machinery expression is also reduced in critical disease. Furthermore, we report that neutrophils contribute to disease severity and local tissue damage by amplification of hypercytokinemia and the formation of neutrophil extracellular traps. Together our findings suggest a myeloid-driven immunopathology, in which hyperactivated neutrophils and an ineffective adaptive immune system act as mediators of COVID-19 disease severity.

Identifiants

pubmed: 34226537
doi: 10.1038/s41467-021-24360-w
pii: 10.1038/s41467-021-24360-w
pmc: PMC8257697
doi:

Substances chimiques

Cytokines 0
Histocompatibility Antigens Class II 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4117

Références

J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Autoimmun Rev. 2020 Jul;19(7):102567
pubmed: 32376392
Inflammation. 2021 Feb;44(1):13-34
pubmed: 33029758
Immunity. 2020 Jun 16;52(6):910-941
pubmed: 32505227
Med. 2021 Jan 15;2(1):99-112.e7
pubmed: 32838362
BMC Bioinformatics. 2018 Dec 7;19(1):470
pubmed: 30526489
Circ Res. 2019 Aug 2;125(4):470-488
pubmed: 31518165
Nat Med. 2020 Jul;26(7):1070-1076
pubmed: 32514174
Cytometry A. 2015 Jul;87(7):636-45
pubmed: 25573116
Genome Biol. 2019 Dec 19;20(1):290
pubmed: 31856883
Blood. 2014 May 1;123(18):2768-76
pubmed: 24366358
Clin Transl Immunology. 2020 Nov 13;9(11):e1204
pubmed: 33209300
Crit Care. 2018 Dec 27;22(1):358
pubmed: 30587204
J Infect. 2020 Jul;81(1):e6-e12
pubmed: 32283162
Sci Adv. 2020 Dec 9;6(50):
pubmed: 33187979
Am J Pathol. 2011 Jul;179(1):199-210
pubmed: 21703402
Blood. 2020 Sep 3;136(10):1169-1179
pubmed: 32597954
Cell Host Microbe. 2016 Feb 10;19(2):181-93
pubmed: 26867177
J Med Virol. 2020 Oct;92(10):1733-1734
pubmed: 32242950
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Front Immunol. 2021 Apr 28;12:661052
pubmed: 33995382
Nucleic Acids Res. 2017 Dec 15;45(22):e179
pubmed: 28981748
Elife. 2020 Feb 14;9:
pubmed: 32057296
Nat Med. 2020 Jun;26(6):842-844
pubmed: 32398875
Sci Immunol. 2020 Jul 10;5(49):
pubmed: 32651212
Immunity. 2020 Sep 15;53(3):685-696.e3
pubmed: 32783921
J Allergy Clin Immunol. 2020 Jul;146(1):119-127.e4
pubmed: 32360286
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
J Leukoc Biol. 2021 Jan;109(1):13-22
pubmed: 33040384
Cell Res. 2021 Mar;31(3):272-290
pubmed: 33473155
Cell Rep Med. 2020 Aug 25;1(5):100078
pubmed: 32838342
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Parasit Vectors. 2017 Jun 6;10(1):285
pubmed: 28583201
Nat Immunol. 2021 Jan;22(1):32-40
pubmed: 33277638
Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):E2393-402
pubmed: 27078110
Int J Mol Sci. 2018 Nov 27;19(12):
pubmed: 30486423
J Clin Invest. 2020 Nov 2;130(11):6151-6157
pubmed: 32759504
Cell Death Differ. 2017 May;24(5):832-843
pubmed: 28234357
Nat Rev Immunol. 2020 Jun;20(6):355-362
pubmed: 32376901
Clin Exp Immunol. 2002 May;128(2):339-46
pubmed: 11985525
Int J Infect Dis. 2005 Nov;9(6):323-30
pubmed: 16095942
EBioMedicine. 2020 Jul;57:102885
pubmed: 32650275
Br J Haematol. 2016 Jul;174(2):175-87
pubmed: 27292929
PLoS One. 2017 Apr 26;12(4):e0176460
pubmed: 28445506
Lancet Respir Med. 2020 Jul;8(7):681-686
pubmed: 32473124
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Front Immunol. 2020 May 01;11:827
pubmed: 32425950
N Engl J Med. 2020 Jun 18;382(25):2411-2418
pubmed: 32379955
Blood. 2011 Aug 4;118(5):e16-31
pubmed: 21653326
Clin Microbiol Infect. 2000 Dec;6(12):657-60
pubmed: 11284925
Cell. 2020 Sep 17;182(6):1419-1440.e23
pubmed: 32810438
Natl Sci Rev. 2020 Jun;7(6):998-1002
pubmed: 34676125
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Front Immunol. 2020 Jul 03;11:1642
pubmed: 32719686
Nat Commun. 2020 Jul 30;11(1):3810
pubmed: 32733001
Cell Discov. 2020 May 4;6:31
pubmed: 32377375
Cell Mol Immunol. 2020 May;17(5):541-543
pubmed: 32203186
Crit Care. 2020 Jul 13;24(1):422
pubmed: 32660650
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32353870
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
Cytokine Growth Factor Rev. 2015 Jun;26(3):263-80
pubmed: 25466631
Nat Commun. 2021 May 17;12(1):2890
pubmed: 34001872
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32302401
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):988-994
pubmed: 33267662
Nat Med. 2020 Oct;26(10):1636-1643
pubmed: 32839624
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Nat Commun. 2019 Apr 2;10(1):1495
pubmed: 30940803
Cell Mol Immunol. 2020 May;17(5):433-450
pubmed: 32238918
Nature. 2020 Jul;583(7816):437-440
pubmed: 32434211

Auteurs

L Vanderbeke (L)

Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

P Van Mol (P)

Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, Leuven, Belgium.

Y Van Herck (Y)

Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.

F De Smet (F)

Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research, Department of Imaging & Pathology, KU Leuven, Leuven, Belgium.

S Humblet-Baron (S)

Adaptive Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

K Martinod (K)

Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

A Antoranz (A)

Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research, Department of Imaging & Pathology, KU Leuven, Leuven, Belgium.

I Arijs (I)

Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, Leuven, Belgium.

B Boeckx (B)

Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, Leuven, Belgium.

F M Bosisio (FM)

Translational Cell & Tissue Research, Department of Imaging & Pathology, KU Leuven, Leuven, Belgium.

M Casaer (M)

Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

D Dauwe (D)

Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

W De Wever (W)

Radiology, Department of Imaging & Pathology, KU Leuven, Leuven, Belgium.

C Dooms (C)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

E Dreesen (E)

Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

A Emmaneel (A)

Department of Applied Mathematics, Computer Science and Statistics, VIB-UGent Center for Inflammation Research, VIB-UGent, Gent, Belgium.

J Filtjens (J)

Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.

M Gouwy (M)

Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.

J Gunst (J)

Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

G Hermans (G)

Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

S Jansen (S)

Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, B Leuven, Belgium.

K Lagrou (K)

Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

A Liston (A)

Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge, UK.

N Lorent (N)

Department of Pneumology, University Hospitals Leuven, Leuven, Belgium.

P Meersseman (P)

Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

T Mercier (T)

Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

J Neyts (J)

Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, B Leuven, Belgium.

J Odent (J)

Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium.

D Panovska (D)

Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research, Department of Imaging & Pathology, KU Leuven, Leuven, Belgium.

P A Penttila (PA)

KU Leuven Flow & Mass Cytometry Facility, KU Leuven, Leuven, Belgium.

E Pollet (E)

Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium.

P Proost (P)

Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.

J Qian (J)

Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, Leuven, Belgium.

K Quintelier (K)

Department of Applied Mathematics, Computer Science and Statistics, VIB-UGent Center for Inflammation Research, VIB-UGent, Gent, Belgium.

J Raes (J)

Laboratory of Molecular Bacteriology (Rega Institute), Department of Microbiology, Immunology and Transplantation, KU Leuven, and VIB Center for Microbiology, Leuven, Belgium.

S Rex (S)

Anesthesiology and Algology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

Y Saeys (Y)

Department of Applied Mathematics, Computer Science and Statistics, VIB-UGent Center for Inflammation Research, VIB-UGent, Gent, Belgium.

J Sprooten (J)

Laboratory for Cell Stress & Immunity (CSI), Department of Cellular and Molecular Medicine (CMM), KU Leuven, Leuven, Belgium.

S Tejpar (S)

Molecular Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.

D Testelmans (D)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

K Thevissen (K)

Centre of Microbial and Plant Genetics, Department of Microbial and Molecular Systems (M2S), KU Leuven, Leuven, Belgium.

T Van Buyten (T)

Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, B Leuven, Belgium.

J Vandenhaute (J)

Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.

S Van Gassen (S)

Department of Applied Mathematics, Computer Science and Statistics, VIB-UGent Center for Inflammation Research, VIB-UGent, Gent, Belgium.

L C Velásquez Pereira (LC)

Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

R Vos (R)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

B Weynand (B)

Translational Cell & Tissue Research, Department of Imaging & Pathology, KU Leuven, Leuven, Belgium.

A Wilmer (A)

Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

J Yserbyt (J)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

A D Garg (AD)

Laboratory for Cell Stress & Immunity (CSI), Department of Cellular and Molecular Medicine (CMM), KU Leuven, Leuven, Belgium.

P Matthys (P)

Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.

C Wouters (C)

Adaptive Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.

D Lambrechts (D)

Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, Leuven, Belgium.

E Wauters (E)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium. els.wauters@kuleuven.be.

J Wauters (J)

Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH